Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases.

about

Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases.

Item

http://www.wikidata.org/entity/Q55253535

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Serum levels of soluble urokin ...... f colorectal liver metastases.

@en

Serum levels of soluble urokinase plasminogen activator receptor

@nl

type

Item

label

Serum levels of soluble urokin ...... f colorectal liver metastases.

@en

Serum levels of soluble urokinase plasminogen activator receptor

@nl

prefLabel

Serum levels of soluble urokin ...... f colorectal liver metastases.

@en

Serum levels of soluble urokinase plasminogen activator receptor

@nl

P1476

Serum levels of soluble urokin ...... f colorectal liver metastases.

@en

P2093

Alexander Koch

http://www.w3.org/2001/XMLSchema#string

Catherine Leyh

http://www.w3.org/2001/XMLSchema#string

Christian Trautwein

http://www.w3.org/2001/XMLSchema#string

Christoph Roderburg

http://www.w3.org/2001/XMLSchema#string

Florian Heitkamp

http://www.w3.org/2001/XMLSchema#string

Frank Tacke

http://www.w3.org/2001/XMLSchema#string

Marcel Binnebosel

http://www.w3.org/2001/XMLSchema#string

Mihael Vucur

http://www.w3.org/2001/XMLSchema#string

Patrick H Alizai

http://www.w3.org/2001/XMLSchema#string

Sven H Loosen

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Colorectal Liver Metastases: A Critical Review of State of the Art

suPAR: the molecular crystal ball

Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Trends in long-term survival following liver resection for hepatic colorectal metastases.

Colorectal cancer statistics, 2017.

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.

Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

Acute kidney injury following hepatectomy for hepatocellular carcinoma: incidence, risk factors and prognostic value.

P304

27027-27038

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25471

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29930748

http://www.w3.org/2001/XMLSchema#string

P932

6007468

http://www.w3.org/2001/XMLSchema#string